by Jennifer P | Jul 13, 2021 | Cosmetics, U.S. Regulatory
New legislation titled the Personal Care Product Safety Act is intended to replace the 83 year old law that currently governs this category of regulated product. The bill, introduced by Senators Feinstein and Collins in mid-June 2021, will help improve safety for...
by Jennifer P | Mar 29, 2021 | OTC Drugs, U.S. Regulatory
In March 2020, provisions were added to the Federal Food, Drug, and Cosmetic Act by the Coronavirus Aid, Relief, and Economic Security (CARES) Act, which authorize FDA to assess and collect user fees from qualifying manufacturers of OTC monograph drugs and submitters...
by Jennifer P | Apr 3, 2019 | Medical Devices, U.S. Regulatory
Most dialysis patients are presented with limited options for having a great quality of life. The quality diminishes further when they must consume 20-30 pills a day and have to put a harsh cap on their amount of fluid intake. Due to kidney dysfunction, they are in...
by Jennifer P | Jan 16, 2019 | Canadian Regulatory
What is a risk assessment of a chemical substance? A risk assessment is an integral part of maintaining both the health of Canadians and the environment. Risk assessments are executed by Environment and Climate Change Canada under the CEPA (Canadian Environmental...
by Jennifer P | Jan 9, 2019 | Research/Science/Technology
A constant victim of media scrutiny, blue light has recently received a lot of negative press with regards to its damaging effects to the skin. Side effects such as hyperpigmentation and oxidative stress have been found to be associated with the exposure of...
Recent Comments